Western Mass Physician Associates INC
Western Mass Physician Associates INC was paid $5.68M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoWESTERN MASS PHYSICIAN ASSOCIATES INC
CHICOPEE, MA 01020
CHICOPEE, MA 01020
33aNPI1922009547assigned 08/04/2005
33bProvider typeMidwife
28Total paid$5.68M
24GClaims167,030
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,685 | $898K | |
| 2019 | 27,086 | $901K | |
| 2020 | 23,772 | $962K | |
| 2021 | 23,359 | $1.09M | |
| 2022 | 22,038 | $1.07M | |
| 2023 | 24,852 | $505K | |
| 2024incomplete | 19,238 | $252K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 62,404 | 58,654 | $2.24M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 38% | 46,459 | 43,911 | $2.13M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 4.4% | 3,914 | 3,804 | $250K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.3% | 5,036 | 5,015 | $128K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | 1.6% | 1,540 | 415 | $91K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.6% | 1,557 | 1,555 | $91K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 1,505 | 1,503 | $75K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.3% | 1,124 | 1,118 | $71K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 960 | 937 | $70K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 5,675 | 5,654 | $60K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,522 | 3,483 | $52K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 764 | 764 | $41K |
68 more codes
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 4,408 | $38K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 8,600 | $34K |
| G0299 | Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes | <1% | 395 | $30K |
| 99173 | <1% | 1,947 | $27K | |
| 90686 | <1% | 2,967 | $26K | |
| 99397 | <1% | 227 | $25K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 243 | $18K |
| 92551 | <1% | 1,858 | $17K | |
| 99443 | <1% | 476 | $14K | |
| 99442 | <1% | 611 | $12K | |
| 99460 | <1% | 124 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 594 | $11K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 258 | $11K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 207 | $9K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 569 | $9K |
| 90688 | <1% | 751 | $9K | |
| 81025 | <1% | 1,328 | $8K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 850 | $8K |
| 96127 | <1% | 700 | $6K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 89 | $5K |
| 99385 | <1% | 44 | $4K | |
| 99188 | <1% | 161 | $4K | |
| 99462 | <1% | 79 | $3K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 99 | $3K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 828 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 69 | $3K |
| 90662 | <1% | 246 | $2K | |
| 0072A | <1% | 51 | $2K | |
| 0071A | <1% | 50 | $2K | |
| 90677 | <1% | 15 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 58 | $2K |
| 90715 | <1% | 65 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 24 | $2K |
| 90732 | <1% | 66 | $1K | |
| 99386 | <1% | 14 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,207 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 102 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 88 | $938.04 |
| 81003 | <1% | 627 | $795.67 | |
| 95117 | <1% | 76 | $648.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 31 | $645.67 |
| 90682 | <1% | 22 | $555.49 | |
| 90480 | <1% | 12 | $522.92 | |
| 99221 | <1% | 15 | $494.03 | |
| S3005 | Performance measurement, evaluation of patient self assessment, depression | <1% | 50 | $431.35 |
| 80305 | <1% | 35 | $257.34 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 20 | $244.52 |
| 85018 | <1% | 107 | $214.80 | |
| 99051 | <1% | 12 | $196.24 | |
| 90670 | <1% | 88 | $183.52 | |
| 96160 | <1% | 254 | $122.26 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 12 | $112.00 |
| 87210 | <1% | 26 | $98.17 | |
| 86580 | <1% | 12 | $75.60 | |
| 81002 | <1% | 14 | $30.84 | |
| 90716 | 0% | 12 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 183 | $0.00 |
| 90651 | 0% | 61 | $0.00 | |
| 90647 | 0% | 52 | $0.00 | |
| 90680 | 0% | 26 | $0.00 | |
| 90697 | 0% | 12 | $0.00 | |
| 99406 | 0% | 13 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 126 | $0.00 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 70 | $0.00 |
| 90685 | 0% | 17 | $0.00 | |
| 90734 | 0% | 40 | $0.00 | |
| 90633 | 0% | 26 | $0.00 | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | 0% | 51 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCANDITO, PHILLIP (VP OF AMBULATORY SERVICES)
Parent organizationVALLEY HEALTH SYSTEMS, INC.